RCKT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Rocket Pharmaceuticals (RCKT) Earnings Date & Reports

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RCKT is expected to report earnings to fall 5.35% to -58 cents per share on May 12

Rocket Pharmaceuticals RCKT Stock Earnings Reports

Q1'25

Est.

$-0.59

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.04

Q2'24

Missed

by $0.02

Q1'24

Beat

by $0.01

The last earnings report on February 27 showed earnings per share of -62 cents, beating the estimate of -72 cents. With 2.89M shares outstanding, the current market capitalization sits at 591.79M.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+31%

VIEW DETAILS VIEW DETAILS

SUBSCRIBE SUBSCRIBE

RCKT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RCKT
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RCKT (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a provider of gene therapy services

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9 Cedarbrook Drive

Phone

+1 609 659-8001

Employees

268

Web

https://www.rocketpharma.com